JAMDA
Volume 8, Issue 2 , Pages 98-104, February 2007

Is Drug Therapy for Urinary Incontinence Used Optimally in Long-Term Care Facilities?

  • Siva Narayanan, MS, MHS

      Affiliations

    • Beverly Enterprises, Fort Smith, AR
    • ,
  • Annamaria Cerulli, MPH

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ
    • Kristijan Kahler and Annamaria Cerulli are employees of Novartis Pharmaceuticals Corporation.
    • ,
  • Kristijan H. Kahler, RPh, MSc, PhD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ
    • Kristijan Kahler and Annamaria Cerulli are employees of Novartis Pharmaceuticals Corporation.
    • Corresponding Author InformationAddress correspondence to Kristijan H. Kahler, Novartis Pharmaceuticals Corporation, US CD&MA/Health Economics & Outcomes Research, One Health Plaza, East Hanover, NJ 07936.
    • ,
  • Joseph G. Ouslander, MD

      Affiliations

    • Emory University and the Birmingham/Atlanta VA GRECC, Atlanta, GA.
    • Professor Ouslander serves as a consultant and lecturer for Novartis Pharmaceuticals Corporation and has received educational grant support from this company. He has also served as an advisor and lecturer for Pfizer. At the time of this study Siva Narayanan was an employee of Beverly Enterprises.

published online 04 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by Novartis Pharmaceuticals Corporation. Preparation of the manuscript was supported by Novartis Pharma AG. Editorial and project management services were provided by ACUMED.

PII: S1525-8610(06)00371-9

doi:10.1016/j.jamda.2006.07.004

JAMDA
Volume 8, Issue 2 , Pages 98-104, February 2007

Article Tools